Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 83Metastatic Castration Resistant Prostate Cancer 9Breast Neoplasms 9Neoplasms 8Neoplasm Metastasis 8Prostatic Neoplasms, Castration-Resistant 6Prostate Cancer Metastatic 4Castration-resistant Prostate Cancer 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Triple Negative Breast Neoplasms 2Non-metastatic Castration-resistant Prostate Cancer 2Metastatic Castration-resistant Prostate Cancer 2Metastatic Castration-Resistant Prostate Cancer 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Ureteral Diseases 1Seizures 1Recurrent Endometrial Endometrioid Adenocarcinoma 1Prostate Carcinoma Metastatic to the Bone 1Primary Dysautonomias 1Primary Breast Cancer ER+ve 1Pharmacokinetics of MDV3100 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-metastatic, Hormone naïve Prostate Cancer 1Non-metastatic Prostate Cancer 1Metastatic Progressive Castration-resistant Prostate Cancer 1

Interventions

enzalutamide 1Water 1Nivolumab 1Mitomycin 1Microscopy 1Gemcitabine 1Gels 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Diseases × enzalutamide × Clear all
NCT02300610 2019-08-01

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
10 enrolled 14 charts
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Ureteral Diseases, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡